Table: begin end state 1 38 cytoplasmic 39 65 transmembrane 66 84 non-cytoplasmic 85 104 transmembrane 105 115 cytoplasmic 116 141 transmembrane 142 168 non-cytoplasmic 169 189 transmembrane 190 195 cytoplasmic 196 219 transmembrane 220 229 non-cytoplasmic 230 248 transmembrane 249 256 cytoplasmic 257 281 transmembrane 282 300 non-cytoplasmic 301 323 transmembrane 324 350 cytoplasmic 351 372 transmembrane 373 425 non-cytoplasmic 426 447 transmembrane 448 467 cytoplasmic 468 486 transmembrane 487 491 non-cytoplasmic 492 510 transmembrane 511 521 cytoplasmic 522 549 transmembrane 550 558 non-cytoplasmic 559 582 transmembrane 583 588 cytoplasmic 589 608 transmembrane 609 613 non-cytoplasmic 614 637 transmembrane 638 648 cytoplasmic 649 668 transmembrane 669 679 non-cytoplasmic 680 703 transmembrane 704 712 cytoplasmic 713 742 transmembrane 743 761 non-cytoplasmic
Input: >WP_085638026.1 NCBI__GCF_002115805.1:WP_085638026.1 MTDPKTAPIDDEPDAPVLAEGVDEEPIESNRRLFSGRAYLLMAGLSTFYAAFHMIALNGV SISAWTGLDLPFLPQFPLETWNFRIAHIAGALALGFLLFSAHTFSDDGPPHKETRAISIL AAILVLPALVSGVTAIGFLNLINSGTLPEMGGLTTWAAFPGTEIYSSEVWWFGTPLLIAT FGAILTGWFERRGRELFAASDVVLALCGLVVAIYLIGIYGTAARNSVGTPFVPIGVAFAA TAGSAMILELTRRVAGLALVIITAVFLVYTFTAHLLPGILAVQSAYSWQRFFGHVYSDAG ILGPTTAVSSTYIILFIIFAAFLQASKVGDYFVNFAFATAGRARGGPAKVAIFASGLMGM INGTSAGNVVATGSLTIPLMKKVGYQKKIAGAVEAGASTGGQIMPPIMGAGAFIMAEITG IPYTDIAIAAIIPAVLYFVSIYFMVDFEAAKLGMRGMREDELPKFNKLVRQVYLFIPILI LIAALFMGYSVIRAGTLATVAAAVVSWFTPNRMGLRSILKAFELAGIMSIQIIAVCACAG IIVGVISLTGVGARFSSVLLDLAGVSQLLALFFAMCIAILLGMGMPTTAAYAVAASVVAP GLVQLGIPQLTAHFFVFYFAVLSAITPPVALASYAAAGISGANPMETSVASFKIGIAAFI VPYMFFYNSALLMDGTWFEVLRAGVTATIGVFLLSSGVQGWFLGGRSAWFLRVALIFAAL FMIEGGLITDLIGVGIAAATFFVQKVVHARPDATIPVRGAD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server